In all, 373 memorandums of understanding (MoUs) have been signed in the healthcare and pharmaceuticals sector during the ongoing Vibrant Gujarat Summit — 273 MoUs worth Rs 8200 crore have been signed in the pharma sector. And 102 in the healthcare sector, said senior government officials. Gujarat accounts for more than one-third of the pharmaceutical production in the country, said P K Parmar, additional chief secretary, state health and family welfare department. Apart from pharma companies, some healthcare and medical institutions also signed MoUs with the state government during a seminar on ‘Shaping a new paradigm in health and pharma’ at Mahatma Mandir in Gandhinagar.
According to government officials, the companies that proposed investments in Gujarat include Puniska Healthcare, Alembic Pharmaceuticals, Amneal Pharmaceuticals, Emcure Pharmaceuticals and Dishman Corbogen Amcis. Addressing the seminar, minister of state for health and family welfare, the Government of India, Ashwani Choubey said that around 15,000 health and wellness centers are set to come up across India, of which 1645 have been approved for Gujarat. “There is a huge investment potential in Gujarat for the pharma and healthcare sector,” he said. – TOI